Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

X4 Pharmaceuticals (XFOR) Receivables - Net (2020 - 2025)

X4 Pharmaceuticals (XFOR) has disclosed Receivables - Net for 3 consecutive years, with $891000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Net changed N/A year-over-year to $891000.0, compared with a TTM value of $891000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $1.1 million, changed N/A over the prior year.
  • Receivables - Net was $891000.0 for Q3 2025 at X4 Pharmaceuticals, down from $1.1 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $1.1 million in Q2 2025 and bottomed at $509000.0 in Q1 2025.